Then that will be a negative clinical trial update and the market will sell the pps down. Are you forgetting the other PR and SD response seen in the patients who are early in the Ph1 clinical trial as well??? I'm amaze even seeing some efficacy in Ph1, did you see them early in Ph1 for Her-Vaxx?
Media Thread, page-12118
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
-0.001(1.45%) |
Mkt cap ! $497.7M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.0¢ | 6.7¢ | $1.242M | 18.24M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1443066 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 671816 | 6 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
-0.001 ( 0.72 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 6.9¢ | 6.7¢ | 6493774 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| IMU (ASX) Chart |